Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
27.26
-0.24 (-0.87%)
Nov 21, 2024, 12:39 PM EST - Market open
Spyre Therapeutics Employees
Spyre Therapeutics had 30 employees as of December 31, 2023. The number of employees decreased by 39 or -56.52% compared to the previous year.
Employees
30
Change (1Y)
-39
Growth (1Y)
-56.52%
Revenue / Employee
n/a
Profits / Employee
-$7,163,400
Market Cap
1.40B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
U.S. Physical Therapy | 6,720 |
Evolent Health | 4,700 |
Myriad Genetics | 2,700 |
Schrödinger | 867 |
Intellia Therapeutics | 526 |
Arvinas | 445 |
Harrow | 315 |
Bicycle Therapeutics | 284 |
SYRE News
- 2 hours ago - Bronstein, Gewirtz & Grossman, LLC Encourages Spyre Therapeutics, Inc. (SYRE) Investors to Inquire about Securities Investigation - Accesswire
- 1 day ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Spyre Therapeutics, Inc. (SYRE) And Encourages Investors to Reach Out - Accesswire
- 2 days ago - Spyre Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock - PRNewsWire
- 2 days ago - Spyre Therapeutics Announces Proposed Public Offering of its Common Stock and Pre-Funded Warrants - PRNewsWire
- 9 days ago - Spyre Therapeutics Announces Positive Interim Results from Phase 1 Healthy Volunteer Trial for SPY001, Its Novel Half-Life Extended anti-α4β7 Antibody for the Treatment of Inflammatory Bowel Disease, with a Half-Life of >90 Days Supporting the Potential for Both Q3M & Q6M Maintenance Dosing - PRNewsWire
- 9 days ago - Spyre Therapeutics to Host Conference Call and Webcast to Report Interim Results from Phase 1 Healthy Volunteer Trial for SPY001, its Novel Half-Life Extended Anti-α4β7 Antibody for the Treatment for Inflammatory Bowel Disease on November 12, 2024 - PRNewsWire
- 13 days ago - Spyre Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update - PRNewsWire
- 19 days ago - Spyre Therapeutics Announces Grants of Inducement Awards - PRNewsWire